Fallica and colleagues [21] report a decrease in serum MIF in COPD patients as a whole compared to healthy smokers; this is mainly due to a marked reduction in MIF levels in GOLD IV patients whilst the GOLD II and III patients have similar serum MIF levels as healthy smokers. Here, MIF is linked to chronic obstructive pulmonary disease.